[ad_1] STOCKHOLM, Dec. 11, 2024 /PRNewswire/ — The Swedish Orphan Biovitrum AB (publ) (Sobi®) EGM was convened today on 11 December 2024. In accordance with the Nomination Committee’s proposals, David Meek was elected as new member […]

[ad_1] STOCKHOLM, Dec. 3, 2024 /PRNewswire/ — New data from Sobi® and partners will be presented at the 66th Annual Meeting of the American Society of Hematology (ASH) in San Diego, CA (USA) from the […]

[ad_1] STOCKHOLM, Nov. 11, 2024 /PRNewswire/ — The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Extraordinary General Meeting (the “Meeting“), to be held on Wednesday, 11 December […]

[ad_1] STOCKHOLM, Nov. 11, 2024 /PRNewswire/ — The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Extraordinary General Meeting (the “Meeting“), to be held on Wednesday, 11 December […]

[ad_1] STOCKHOLM, Oct. 30, 2024 /PRNewswire/ — Sobi® (STO: SOBI) today announced that new research showing the effect of emapalumab in patients with macrophage activation syndrome (MAS) in Still’s disease, including systemic juvenile idiopathic arthritis […]